There has been an increase in the use of fetal ultrasound in the first trimester over the last few years. This paper will review the published literature on first trimester ultrasound screening programmes for both aneuploidy and fetal structural abnormalities. 1997 by John Wiley & Sons, Ltd.
First trimester ultrasonography in screening and detection of fetal anomalies
โ Scribed by Jiri Sonek
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 281 KB
- Volume
- 145C
- Category
- Article
- ISSN
- 1552-4868
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Figure 1. Ultrasound findings and anatomical correlates. a: Severe biventricular hydrocephalus. b: Severe microretrognathia. c: Left hand, with only two digits of two phalanges each. d: Ectrodactyly of the right hand. e: Ectrodactyly of the left foot.
The aim of this screening study was to evaluate first-trimester screening for chromosomal defects by fetal nuchal translucency thickness at 10-14 weeks of gestation in four Fetal Medicine Units in Greece. Estimates of the risk for trisomy 21 were calculated taking into account fetal nuchal transluce
Prenatal screening for fetal abnormalities in an accepted part of modern obstetric management. Improvements on current screening procedures need to address increased diagnostic efficacy and earlier diagnosis. This study evaluates diagnostic efficacy of PAPP-A and F beta-hCG in the detection of first
Two groups of pregnant women were questioned regarding their opinions on serum screening for Down's syndrome in the first trimester of pregnancy. One group comprised 83 women attending our antenatal clinic who were questioned at the time of the existing second-trimester screening test. Seventy-six p
The aim of this study was to evaluate the feasibility of first-trimester biochemical screening for trisomy 18, by using pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (hCG) in combination with maternal age. Maternal serum levels of PAPP-A and free beta-hCG